Paul L. Hallenbeck
Fondatore presso Seneca Therapeutics, Inc.
Posizioni attive di Paul L. Hallenbeck
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Seneca Therapeutics, Inc.
 Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Seneca Therapeutics, Inc. operates as a biotechnology company. It develops novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. The company was founded by Paul L. Hallenbeck and is headquartered in Blue Bell, PA. | Direttore/Membro del Consiglio | - | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Fondatore | - | - | |
| Presidente | - | - | |
| Amministratore Delegato | - | - |
Storia della carriera di Paul L. Hallenbeck
Precedenti posizioni note di Paul L. Hallenbeck
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Synbody Biotechnology, Inc.
 Synbody Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA. | Direttore/Membro del Consiglio | 01/01/2010 | 01/01/2013 |
| Amministratore Delegato | 01/01/2010 | 01/01/2013 | |
| Fondatore | 01/01/2010 | 01/01/2013 | |
| Presidente | 01/01/2010 | - | |
| Nisco International Ltd. | Presidente | - | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | 22/02/2011 | - |
Neotropix, Inc.
 Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Direttore Tecnico/Scientifico/R&S | 01/01/2003 | - |
| Fondatore | 01/01/2003 | - | |
| Presidente | 16/02/2010 | - |
Formazione di Paul L. Hallenbeck
| Siena College | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Regno Unito | 2 |
Posizioni
| President | 4 |
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
Neotropix, Inc.
Neotropix, Inc. BiotechnologyHealth Technology Neotropix, Inc. develops virus-based therapies for cancer treatment. It has developed NTX-010 virus, a small cell lung cancer treatment and as a treatment of pediatric cancers, such as neuroblastoma. The company was founded by Paul L. Hallenbeck in 2003 and is headquartered in Malvern, PA. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Synbody Biotechnology, Inc.
Synbody Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA. | Health Technology |
Seneca Therapeutics, Inc.
Seneca Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Seneca Therapeutics, Inc. operates as a biotechnology company. It develops novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. The company was founded by Paul L. Hallenbeck and is headquartered in Blue Bell, PA. | Commercial Services |
| Nisco International Ltd. |
- Borsa valori
- Insiders
- Paul L. Hallenbeck
- Esperienza
